https://adisinsight.springer.com/drugsafety/803915445?error=cookies_not_supported&code=2467a328-83ad-4863-a69b-bb69d8cfd183
Fluorouracil/Irinotecan/Rucaparib - AdisInsight
In a phase 1 study, 18 patients with metastatic gastrointestinal cancers who had previously progressed on at least one systemic therapy received a combination
fluorouracilirinotecanrucaparib
https://www.urologytimes.com/view/maintenance-rucaparib-shows-promise-in-urothelial-carcinoma-with-dna-repair-deficiency
Maintenance rucaparib shows promise in urothelial carcinoma with DNA repair deficiency | Urology...
Oct 10, 2026 - In a phase 2 trial, patients with metastatic urothelial carcinoma and DNA repair deficiency who had not progressed on chemotherapy were randomized to either...
urothelial carcinomadna repairmaintenancerucaparibshows
https://www.biospace.com/clovis-oncology-announces-availability-and-reimbursement-for-rubraca-rucaparib-tablets-for-women-with-relapsed-ovarian-cancer-in-france
Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women...
Feb 3, 2020 - Rubraca® (rucaparib) offers a new monotherapy maintenance treatment option for eligible women with relapsed, platinum-sensitive ovarian cancer, who harbor...
clovis oncologyannouncesavailabilityreimbursementrucaparib
https://www.alldaygeneric.com/product/rucaparib-200mg-tablet/
Buy Rucaparib 200mg Tablet Online: View Uses, Side Effects, Price, Substitutes | Alldaygeneric
Rucaparib 200mg Tablet is used in the treatment of Prostate cancer, Ovarian cancer. Find Rucaparib 200mg Tablet uses, composition, side-effects, price,...
side effectsprice substitutesbuyrucaparibtablet
https://pure.johnshopkins.edu/en/publications/triumph-phase-ii-trial-of-rucaparib-monotherapy-in-patients-with-/
TRIUMPH: Phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive...
phase ii trialtriumphrucaparibmonotherapypatients
https://www.drozdogan.com/prostat-kanserinde-brca-mutasyonu-icin-rucaparib-tam-fda-onayi-aldi/
Prostat Kanserinde BRCA Mutasyonu İçin Rucaparib Tam FDA Onayı Aldı
Rucaparib (Rubraca) için metastatik kastrasyona dirençli prostat kanseri olan ve daha önce AR hedefli tedavi almış BRCA mutasyonlu hastalarda onay aldı.
prostatbrcamutasyonurucaparibtam